Purchase Order 75N91022P00941
Award Date
9/27/22
Potential Completion Date
9/30/22
Potential Value
$98K
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bohemia, NY 11716, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Sartorius Stedim North America Inc., a division of the German company Sartorius Aktiengesellschaft. The $23,165.00 contract is for the delivery of unspecified biological products or services, with a performance period ending on August 1, 2025. The award was made on February 1, 2025, and there is no set-aside designation....
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The $15,969.40 contract is for a service agreement to provide the NCI with the S3 IncuCyte live-cell analysis system, which supports cutting-edge biomedical research across infectious diseases, cancer studies, and translational sciences....
This federal contract awarded to Sartorius Corporation provides one (1) IncuCyte S3 live-cell analysis system for use by the National Cancer Institute's (NCI) Center for Cancer Research (CCR), Oncogenomic Section. The contract, valued at $125,052.76, is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH). The system will support ongoing cancer research at the CCR, including CRISPR-based genetic screens, drug...
This is a $26,780.00 firm fixed price purchase order awarded to Cellgenix USA, a division of Cellgenix GmbH, by the National Institutes of Health (NIH) Clinical Center. The contract is for the provision of various cytokines, growth factors, and other pharmaceuticals to support cell and gene therapy research and development. No set aside designation was used for this award. Cellgenix USA has previously held other prime federal contracts with the NIH Clinical Center and National Institute of...
The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, awarded a $15,656.00 firm-fixed-price purchase order to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The service contract is for the Sartorius Incucyte S3, a live-cell analysis system used to support the NCI's biomedical research and development initiatives, particularly in areas such as infectious diseases, cancer, and drug...
The National Institutes of Health (NIH) Clinical Center awarded a Firm Fixed Price Purchase Order contract worth $138,390.00 to Cellgenix USA, a division of Cellgenix GMBH. The contract is for the delivery of specialized cell therapy-related pharmaceuticals such as FLT-3L, SCF, TPO, GM-CSF, and interleukin-4 to support cell and gene therapy research and development at the NIH. Cellgenix USA has provided similar products to the NIH and the National Institute of Allergy and Infectious Diseases...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $103,103.00 firm fixed-price purchase order contract to Cellgenix USA, a division of Cellgenix GMBH, a for-profit manufacturer of goods. The contract, which had no set-aside designation, is for the provision of specialized cell therapy-related pharmaceuticals such as FLT-3L, SCF, TPO, GM-CSF, interleukin-4, and other cell therapy reagents to support federal cell and gene therapy research...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to Sartorius Corporation valued at fourteen thousand five hundred forty-four dollars and fifty-two cents ($14,544.52) to cover a Sartorius IncuCyte system under a service contract for the agency's Genetics Branch. Performance will take place from November 24, 2023 through November 23, 2024 at the agency's campus in Bethesda, Maryland. No set-aside...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $10,594.50 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The contract requires Miltenyi Biotec to deliver various cell...
This is a $24,999.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment and reagents. The contract is for the delivery of unspecified laboratory equipment, with a period of performance through September 7, 2024. While not awarded under a set-aside program, Miltenyi Biotec has extensive...